Cocrystal Pharma, Inc.
COCP
$1.55
$0.0050.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 29.94% | 5.38% | 2.67% | -3.78% | 8.32% |
| Total Depreciation and Amortization | -67.53% | -50.48% | -33.33% | 200.00% | 16.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.83% | -6.19% | -4.32% | -13.28% | -19.61% |
| Change in Net Operating Assets | -150.64% | 197.93% | -94.02% | 36.95% | 171.88% |
| Cash from Operations | 5.86% | 7.08% | -12.40% | -2.58% | 36.74% |
| Capital Expenditure | 100.00% | 100.00% | 93.22% | 5.63% | 49.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 100.00% | 93.22% | 5.63% | 49.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -100.00% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.30% | -22.92% | -52.84% | -35.17% | 23.31% |